Therefore, pregnant women may modulate inflammation through CD39+ or CD73+ monocytes; these monocytes, as suggested for the general population, could be a potential marker to monitor the evolution of pregnant women hospitalized for COVID-19. Here, ENTPD1 is linked to COVID-19.